The Motley Fool

Key Data Points

Primary metrics and data points about Celgene.
Current Price: $114.72
Prev Close: $118.71
Open: $119.20
Bid: $114.90
Ask: $114.95
Day's Range: $114.31 - $119.38
52wk Range: $69.88 - $129.06
Volume: 6,813,283
Avg Vol 5,914,440
Market Cap: $92B
P/E (ttm): 49.67
EPS (ttm): $2.39
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Celgene.

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

CELG vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Celgene.
CAPS Rating 5 out of 5
 
1958 Outperform
74 Underperform
CAPS All Stars
 
500 Outperform
13 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Hugin, CEO

93% Approve

Based on 50 Ratings

More Details for CelgeneJobs

Powered by

More Details about Celgene

Primary metrics and data points about Celgene.